Defining outcomes for β-cell replacement therapy in the treatment of diabetes

Autor: Peter A. Senior, Marie-Christine Vantyghem, Lorenzo Piemonti, James Shaw, Esther Latres, Johann Pratschke, François Pattou, Eelco J.P. de Koning, Barbara Ludwig, Paul Johnson, Thierry Berney, Raja Kandaswamy, Rodolfo Alejandro, Roger Lehmann, James F. Markmann, Steven A. White, Thomas W.H. Kay, Robert M. Langer, Jon S. Odorico, Marjana Marinac, Michael R. Rickels, Bart Keymeulen, Peter G. Stock, Pratik Choudhary, Melena D. Bellin, Yogish C. Kudva

Publikováno v: Transplant International, 31(4), 343-352
Transplantation, 102(9), 1479-1486
Transplantation, 102(9), 1479-1486. Lippincott Williams & Wilkins
Transplantation, Vol. 102, No 9 (2018) pp. 1479-1486
Transplant International, Vol. 31 (2018) pp. 343-352
Transplant International
Transplant international : official journal of the European Society for Organ Transplantation, 31(4), 343-352. Wiley-Blackwell

β-cell replacement therapy, available currently as pancreas or islet transplantation, has developed without a clear definition of graft functional and clinical outcomes. The International Pancreas and Islet Transplant Association and European Pancre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b42b8c33dd5c977d9389f2cc5eb39ad
https://doi.org/10.1111/tri.13138

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.